Identify non hereditary progression factors
- Trial ID
- NCT03508960
- Official Title
- The Chinese Early-onset Parkinson's Disease Registry
- Goal
- Identify non hereditary progression factors
- Status
- RECRUITING
- Sponsor
- Xiangya Hospital of Central South University
- Study Type
- OBSERVATIONAL
- Enrollment
- 3000 participants
- Conditions
- Parkinson Disease
Plain-Language Summary
The goal is to build a large registry to better understand early-onset Parkinson's in Chinese patients, especially how symptoms begin, change over time, and what non-hereditary factors might be linked to the disease. The approach is observational, enrolling up to 3,000 people diagnosed by standard criteria including the UK Brain Bank, and collecting clinical data and medical history over time so researchers can map patterns, progression, and potential biomarkers. Eligible participants are adults whose Parkinson's symptoms started at age 50 or younger, diagnosed by UKBB or equivalent criteria, and who do not have a family history of PD.
Locations
- Xiangya Hospital of Central South University, Changsha, Hunan, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to build a large registry to better understand early-onset Parkinson's in Chinese patients, especially how symptoms begin, change over time, and what non-hereditary factors might be linked to the disease. The approach is observational, enrolling up to 3,000 people diagnosed by standard criteria including the UK Brain Bank, and collecting clinical data and medical history over time so researchers can map patterns, progression, and potential biomarkers. Eligible participants are adults whose Parkinson's symptoms started at age 50 or younger, diagnosed by UKBB or equivalent criteria, and who do not have a family history of PD.
- Who can participate?
- Participants must be 50 Years or younger.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 10 years.